Detailed Review Of Prospects For Predictive Oncology Inc Stock

A share price of Predictive Oncology Inc [POAI] is currently trading at $1.47, up 2.80%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The POAI shares have gain 9.70% over the last week, with a monthly amount glided 113.17%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Predictive Oncology Inc [NASDAQ: POAI] stock has seen the most recent analyst activity on August 19, 2024, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $3.

Predictive Oncology Inc experienced fluctuations in its stock price throughout the past year between $0.55 and $3.76. Predictive Oncology Inc [NASDAQ: POAI] shares were valued at $1.47 at the most recent close of the market.

Analyzing the POAI fundamentals

Trailing Twelve Months sales for Predictive Oncology Inc [NASDAQ:POAI] were 1.38M which represents -51.66% decline. Gross Profit Margin for this corporation currently stands at 0.08% with Operating Profit Margin at -9.58%, Pretax Profit Margin comes in at -9.54%, and Net Profit Margin reading is -10.13%. To continue investigating profitability, this company’s Return on Assets is posted at -1.86, Equity is -3.04 and Total Capital is -3.59. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.22.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3867 points at the first support level, and at 1.3034 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.5766, and for the 2nd resistance point, it is at 1.6832.

Ratios To Look Out For

To put it in perspective, the Current Ratio for Predictive Oncology Inc [NASDAQ:POAI] is 1.20. In addition, the Quick Ratio stands at 1.06 and the Cash Ratio stands at 0.81. Considering the valuation of this stock, the price to sales ratio is 7.10, the price to book ratio is 4.98.

Related Posts